
Opinion|Videos|October 12, 2023
Leveraging MRI and Fusion-Guided Biopsy for Active Surveillance in Prostate Cancer
Author(s)Amir H. Lebastchi, MD
Amir H. Lebastchi, MD, outlines his general strategy for active surveillance in prostate cancer patients, emphasizing the role of MRI and fusion-guided prostate biopsy.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study shows durable 3-year outcomes with first-line gemcitabine/docetaxel in NMIBC
2
Kathryn Gessner, MD, PhD, on the challenges of selecting patients for bladder preservation
3
Experts discuss the challenge of detecting CIS in bladder cancer
4
First-in-human bladder transplant demonstrates sustained function at 6 months
5













